because NEDS does not report on hospital costs, payments, or out-of-pocket expenses, these data could not be evaluated.
Performance of the Simplified American Academy of Pediatrics Table to Screen Elevated Blood Pressure in Children
In 2017, the American Academy of Pediatrics (AAP) updated the clinical practice guideline for diagnosis and treatment of high blood pressure (BP) in children and adolescents (hereafter referred to as the AAP guideline). 1 Similar to other pediatric BP guidelines, 2,3 the AAP guideline is based on several hundreds of sex-, age-, and height-specific BP cutoffs, which is cumbersome to use in clinical practice. However, the AAP guideline also provides a simplified table based on the 90th BP percentiles at the 5th height percentile as a convenient tool to screen for elevated BP in children aged 1 to 12 years (hereafter referred to as the simplified AAP table). 1 In a recent publication, 4 we assessed simplified BP tables based on different height percentiles for screening elevated BP in children. In this study, we assessed the performance of the simplified AAP table vs the AAP guideline for screening children with elevated BP according to sex, race/ethnicity, BP status, and weight status.
Methods | We used data from 6816 children aged 8 to 12 years from 9 cycles of the National Health and Nutrition Examination Survey (NHANES 5 ) conducted from 1999-2000 to 2015-2016 and from 3145 children aged 5 to 12 years from NHANES III conducted between 1988 and 1994. Adolescents aged 13 to 17 years were not included because the AAP guideline recommends only one BP cutoff for them (120/80 mm Hg). We used the average of the second and third BP readings for data analyses.
We compared the performance of the simplified AAP table to predict elevated BP as defined by the AAP guideline. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were estimated by receiver operating characteristic curve analysis. The NHANES data are freely open and available to the public; thus, institutional review board approval was not required.
Results | The prevalence of elevated BP was 12.1% in children aged 8 to 12 years in NHANES and 7.5% in children aged 5 to 12 years in NHANES III according to the AAP guideline. Comparing the simplified AAP table with the AAP guideline to predict elevated BP, sensitivity (99.9%) and NPV (100.0%) were optimal, but specificity was not optimal (84.4%), resulting in low PPV (46.9%) in NHANES ( Table 1) . Results were similar according to sex, race/ ethnicity, BP status, and body mass index category. These indexes were similar using data from NHANES III (88.4% specificity and 45.1% PPV) ( Table 2) .
Discussion | Because the simplified AAP table is based on BP cutoffs at a low height percentile (fifth) and because height is the major driver of BP in children, it is no surprise that the sensitivity and NPV of the simplified AAP table are optimal, resulting in virtually no false-negative cases. However, the tradeoff for high sensitivity of the AAP guideline at a low height percentile was a low specificity (<89%) and a subsequently low PPV. With a PPV as low as 46.9%, less than half of all children with a positive test result actually had elevated BP. Tables of BP cutoffs based on low child height percentiles are bound to produce high rates of false-positive cases. The aim of the study that was published in the Journal of Hypertension was "to assess the performance of the simplified AAP table and six other simplified tables across different height percentiles in predicting elevated BP in US children." 2 We erroneously noted in the subsequently published JAMA Pediatrics article that the AAP table "has never been evaluated to date" and failed to cite the related study in Journal of Hypertension that had done so.
Our study in JAMA Pediatrics 1 differs from our study in the Journal of Hypertension in several aspects. While the 2 studies provide estimates of overall performance at the fifth height percentile, the article in the Journal of Hypertension reports overall performance indices according to different height percentiles, while the article in JAMA Pediatrics provides reports on the performance at the fifth percentiles according to several covariates (sex, race, blood pressure status, and body mass index status). In addition, the focus of the 2 publications 2,3 is different, as reflected by the different (but not incompatible) conclusions of the 2 studies. In the JAMA Pediatrics article, we conclude that "the simplified AAP table had perfect sensitivity but limited specificity, resulting in large proportions of false-positive cases. Further research is needed to determine which screening tool would be easier to implement in routine clinical practice so more children are screened." 1 The main direct implication of our conclusion in the JAMA Pediatrics article is that alternative screening tools (possibly based on other approaches, such as absolute height) could be useful for mass screening in selected circumstances. In contrast, the focus of the study in the Journal of Hypertension article 2 is on which child height cutoffs could be most suitable in the simplified AAP table, given that different height cutoffs result in different yields of falsepositive and false-negative cases. The main direct implication of this article is that simplified AAP tables based on cutoffs other than fifth percentile height could be useful depending on the purpose of the screening. Given the overlapping nature of the data and methods of these 2 studies and the timing of submission, acceptance, and publication, we should have included references to each study in the respective articles, and we should have notified the editors of both journals of the related studies. We apologize to the readers and editors of both journals and have requested a correction 3 to the JAMA Pediatrics article 1 to include mention of and reference to the study published in the Journal of Hypertension.
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Minding Our Metaphors
To the Editor We suspect that as a neuropsychiatry and behavioral health trainee, Loper would never think to use a term such as retarded or imbecilic to describe someone or something. And yet he-and the reviewers and editors at JAMA Pediatricshave used "acquired physician autism" to describe an unfortunate feature of the practice of medicine today. 1 It is an analogous slur to the R word. We should heed the example of history-from immigrants being described as plagues to German Jews being called a cancer-not to use illness terms or metaphors to describe what is wrong with a group of people. Not only does this practice pathologize the second group, but it reinforces the negative connotations associated with the first group. Persons on the autism spectrum are neurologically different, not broken. Furthermore, they have no choice in the matter, unlike us practicing physicians who are so often the face of modern medicine (when not hidden behind a computer screen!). While we sympathize with Loper's difficulties in balancing his compassion for his patients with the administrative expectations with which he is yoked, we do not believe that the issue is any more illuminated by making an analogy to a neurodevelopmental condition than headlines that mistakenly use schizophrenic to mean of 2 minds. or ritualized patterns of verbal or nonverbal behavior. 3. Highly restricted, fixated interests that are abnormal in intensity or focus. 4. Hyperreactivity or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment. Despite many revisions to the DSM, the word autism has been retained in our professional vernacular. The core features of autism are taught in our medical schools. The diagnostic criteria for autism spectrum disorder are taught in our residency training programs. This is the language that is included on our shelf tests, step examinations, and our board examinations. This is the language that we are trained to use to describe autism in peer-to-peer clinical interactions. We are trained to identify the above features in our patients as consistent with a disorder, as doing so affords them access to evidence-based interventions. The word autism is professionally familiar, and the language that conveys the core features and behaviors of autism spectrum disorder is professionally normative.
When a diagnosis is referenced in a medical journal, it is understood that the diagnosis does not begin to account for the complexity of an individual who has been diagnosed. The individual who has been diagnosed as having autism
